載入...

Preliminary study of the efficacy of xamoterol in bradycardia-tachycardia syndrome.

Following 4 weeks on placebo, eighteen patients with bradycardia-tachycardia syndrome (BTS) were treated with 100 mg xamoterol twice daily for 2-4 weeks. Ambulatory 24 h Holter electrocardiogram recordings showed that xamoterol decreased maximum heart rate from 140 +/- 5.1 to 107 +/- 6 beats min-1 (...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Mizutani, N, Kobayashi, T, Watanabe, T
格式: Artigo
語言:Inglês
出版: 1994
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC1364804/
https://ncbi.nlm.nih.gov/pubmed/7826834
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!